UPDATE: Cowen and Company Upgrades OraSure Following Reduced Launch Expectations
July 16, 2013 at 11:31 AM EDT
In a report published Tuesday, Cowen and Company analyst Shaun Rodriguez upgraded OraSure Technologies (NASDAQ: OSUR ) from Market Perform to Outperform, and reiterated the $6.60 price target. In the report, Cowen and Company noted, “We believe investor expectations for HIV-OTC launch have been appropriately reduced. With shares trading 60%
